Becton Dickinson & Co. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR2.89 |
Market Cap |
EUR60.99 B |
Shares Outstanding |
267.56 M |
Public Float |
198.63 M |
Becton Dickinson & Co. | |
Stock Exchange | New York Stock Exchange |
EPS |
$3.37 |
Market Cap |
$68.57 B |
Shares Outstanding |
269.73 M |
Public Float |
268.1 M |
Address |
1 Becton Drive Franklin Lakes New Jersey 07417 United States |
Employees | - |
Website | http://www.bd.com |
Updated | 07/08/2019 |
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. |